116 related articles for article (PubMed ID: 34864525)
1. Modeling oral cancer screening in the United States population.
Cramer JD; Grauer J
Oral Oncol; 2022 Jan; 124():105656. PubMed ID: 34864525
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
[TBL] [Abstract][Full Text] [Related]
3. Risk-Based Selection of Individuals for Oral Cancer Screening.
Cheung LC; Ramadas K; Muwonge R; Katki HA; Thomas G; Graubard BI; Basu P; Sankaranarayanan R; Somanathan T; Chaturvedi AK
J Clin Oncol; 2021 Feb; 39(6):663-674. PubMed ID: 33449824
[TBL] [Abstract][Full Text] [Related]
4. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?
Pinsky PF; Berg CD
J Med Screen; 2012 Sep; 19(3):154-6. PubMed ID: 23060474
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer risk by years since quitting in 30+ pack year smokers.
Pinsky PF; Zhu CS; Kramer BS
J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
[TBL] [Abstract][Full Text] [Related]
7. Population impact of lung cancer screening in the United States: Projections from a microsimulation model.
Criss SD; Sheehan DF; Palazzo L; Kong CY
PLoS Med; 2018 Feb; 15(2):e1002506. PubMed ID: 29415013
[TBL] [Abstract][Full Text] [Related]
8. Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.
National Lung Screening Trial Research Team
J Thorac Oncol; 2019 Oct; 14(10):1732-1742. PubMed ID: 31260833
[TBL] [Abstract][Full Text] [Related]
9. Evaluating efficacy of current lung cancer screening guidelines.
Nemesure B; Plank A; Reagan L; Albano D; Reiter M; Bilfinger TV
J Med Screen; 2017 Dec; 24(4):208-213. PubMed ID: 28201949
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of lung cancer and lung cancer screening programs in China and the United States.
Yang D; Liu Y; Bai C; Wang X; Powell CA
Cancer Lett; 2020 Jan; 468():82-87. PubMed ID: 31600530
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.
Tammemägi MC; Church TR; Hocking WG; Silvestri GA; Kvale PA; Riley TL; Commins J; Berg CD
PLoS Med; 2014 Dec; 11(12):e1001764. PubMed ID: 25460915
[TBL] [Abstract][Full Text] [Related]
12. Population-based screening program for reducing oral cancer mortality in 2,334,299 Taiwanese cigarette smokers and/or betel quid chewers.
Chuang SL; Su WW; Chen SL; Yen AM; Wang CP; Fann JC; Chiu SY; Lee YC; Chiu HM; Chang DC; Jou YY; Wu CY; Chen HH; Chen MK; Chiou ST
Cancer; 2017 May; 123(9):1597-1609. PubMed ID: 28055109
[TBL] [Abstract][Full Text] [Related]
13. Cervical and oral cancer screening in India.
Sankaranarayanan R; Dinshaw K; Nene BM; Ramadas K; Esmy PO; Jayant K; Somanathan T; Shastri S
J Med Screen; 2006; 13 Suppl 1():S35-8. PubMed ID: 17227640
[TBL] [Abstract][Full Text] [Related]
14. Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening.
Katki HA; Kovalchik SA; Petito LC; Cheung LC; Jacobs E; Jemal A; Berg CD; Chaturvedi AK
Ann Intern Med; 2018 Jul; 169(1):10-19. PubMed ID: 29800127
[TBL] [Abstract][Full Text] [Related]
15. Treatment capacity required for full-scale implementation of lung cancer screening in the United States.
Blom EF; Ten Haaf K; Arenberg DA; de Koning HJ
Cancer; 2019 Jun; 125(12):2039-2048. PubMed ID: 30811590
[TBL] [Abstract][Full Text] [Related]
16. Dilemmas of oral cancer screening: an update.
Kujan O; Sloan P
Asian Pac J Cancer Prev; 2013; 14(5):3369-73. PubMed ID: 23803131
[TBL] [Abstract][Full Text] [Related]
17. Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening.
Pinsky PF; Kramer BS
J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26483244
[TBL] [Abstract][Full Text] [Related]
18. Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.
Fu M; Travier N; Martín-Sánchez JC; Martínez-Sánchez JM; Vidal C; Garcia M;
PLoS One; 2018; 13(4):e0195441. PubMed ID: 29621354
[TBL] [Abstract][Full Text] [Related]
19. [Economic impact of lung cancer screening in France: A modeling study].
Gendarme S; Perrot É; Reskot F; Bhoowabul V; Fourre G; Souquet PJ; Milleron B; Couraud S
Rev Mal Respir; 2017 Sep; 34(7):717-728. PubMed ID: 26585377
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]